Starling Oncology, Inc.
STLN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$512.91M
Close$
$-5.97
189.8% downside
Current Fair Value
189.8% downsideOvervalued by 189.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $512.91 Million |
|---|---|
| Enterprise Value | $578.45 Million |
| Earnings per Share | $-0.54 |
| Beta | 0.42 |
| Outstanding Shares | 103,031,493 |
Return
| Return on Equity | 145.67% |
|---|---|
| Return on Assets | -20.36% |
| Return on Invested Capital | -35.30% |
Valuation & Multiples
| P/E Ratio | -22.1 |
|---|---|
| PEG | 52.06 |
| Price to Sales | 1.33 |
| Price to Book Ratio | -6.65 |
| Enterprise Value to Revenue | 0.99 |
| Enterprise Value to EBIT | -19.67 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | -4.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
$155.74 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About DFP Healthcare Acquisitions Corp
641 employees
CEO: Daniel Virnich
DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more ...